This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine's Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
GTA 6 fever hits the workplace: Maltese employees are already booking launch day off
Rockstar Games’ long-awaited title is set for release on 19th November 2026.
Neriku unveils a new identity for its next chapter
The new positioning moves the brand towards a more contemporary, experience-led approach.
Denise Xuereb on Verdala Hotel: ‘Meaningful design begins with respect for place and heritage’
Verdala Wellness Hotel opened its doors in August 2025 and has since received three European Property Awards.
‘Few generations have the privilege of taking a company into its second century’ – Michael Farrugia
His comments were made at The Cause for Applause employee recognition programme.
